Calibrate Metabolic Reset
Comprehensive weight loss program combining GLP-1 medication, 1:1 coaching, and metabolic health education
Platform · Cloud SaaSCompany source
Company profile
About Calibrate
Calibrate is a digital health company specializing in metabolic health and sustainable weight loss through its comprehensive Metabolic Reset program. The company takes a biology-first approach, recognizing that traditional diets fail because sustainable weight loss comes from improving metabolic health rather than calorie counting or willpower alone. Calibrate's program combines three core components: clinician-prescribed GLP-1 medications (such as Wegovy, Ozempic, Mounjaro, Zepbound, and Foundayo), personalized 1:1 video coaching sessions, and a science-backed educational curriculum covering food, exercise, sleep, and emotional health. The program is structured in progressive phases over 12+ months, moving from learning fundamentals to practicing habits to sustaining long-term results. Calibrate serves both individual consumers and employer-sponsored members, with many companies covering the program cost for employees and dependents. The company provides full-service insurance navigation to help members access affordable GLP-1 medications, typically capped at $25/month for those with commercial insurance. With clinically-reviewed results showing members achieve an average of 19% weight loss achieved over three years, Calibrate positions itself as the first and most experienced program built around GLP-1 medications, backed by a 10%+ weight loss guarantee or money-back eligibility.
Company description Calibrate official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Calibrate?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Metabolic health disorders
- Obesity
- Weight management
Who it serves
- Employer-sponsored members
- Health plan members
- Individual consumers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Insurance systems for benefits verification and navigation, Smart scale integration.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Introduced flexible monthly payment model at $199/month (previously may have required larger upfront payment). Expanded GLP-1 medication options to include Foundayo, Zepbound, Wegovy, Ozempic, and Mounjaro.
Partnerships
Recorded partners
- Commercial/employer insurance plans
- Lab testing facilities
- Pharmacy networks for GLP-1 medication fulfillment
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Evolution of Remote Care.Sexually transmitted diseases · Aug 5, 2022
Clinical validation
Clinical-trial records
Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive AphasiaNCT07511179 · Mentioned · NOT YET RECRUITING
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive ImpairmentNCT07512193 · Mentioned · NOT YET RECRUITING
Research of Integrated Traditional Chinese and Western Medicine on Precocious PubertyNCT07325903 · Mentioned · WITHDRAWN
Digital Audiometer vs. Conventional Audiometer (Gold Standard): Study of Tonal and Vocal Recognition ThresholdsNCT07458477 · Mentioned · COMPLETED
Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult OncologyNCT06897137 · Mentioned · RECRUITING
Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease PatientsNCT06627114 · Mentioned · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
19% average weight loss achieved over 3 years
Average member results
16% weight loss at 12 months
Clinically-reviewed Results Report
17% weight loss at 24 months
Clinically-reviewed Results Report
8 out of 10 members say more effective than other programs
Member satisfaction
10%+ weight loss guarantee
Money-back guarantee after 3-month commitment
Calibrate Members (Aggregate)
Sustainable weight loss through metabolic health improvement
19% average weight loss achieved over three years; 16% at 12 months, 17% at 24 months; 8 out of 10 members say Calibrate is more effective than other programs they've tried
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Calibrate
Recent articles published on Calibrate's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
Mountain Towns Band Together to Crack the Code on Rural Mental Health Crisis
Pooling mental health data across twelve isolated mountain communities reveals hidden behavioral health crises driven by seasonal work instability and geographic isolation.
Mental & Behavioral Health · Jun 26, 2026
Inside Interoception: The hidden sense of how you feel inside
This internal sensing system continuously monitors heart rate, breathing, and metabolic states—and disruptions may explain why patients feel anxious or unwell without obvious cause.
Clinical AI · Jun 18, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.